Research

A new review points to allopurinol as an adjunct therapy for Marfan syndrome

A review article led by Gustavo Egea, head of the Translational Vascular Biology research group  at IDIBAPS and professor at the University of Barcelona, analyses the scientific evidence available on the use of allopurinol as a complementary treatment for Marfan syndrome. The study has been published in the journal Cardiovascular Drugs and Therapy.

Keep reading about: